Serfibrate is a fibrate-class lipid-lowering agent primarily indicated for the treatment of hypertriglyceridemia and mixed dyslipidemia. By inhibiting hepatic triglyceride lipase, the drug enhances the… Read more
Serfibrate is a fibrate-class lipid-lowering agent primarily indicated for the treatment of hypertriglyceridemia and mixed dyslipidemia. By inhibiting hepatic triglyceride lipase, the drug enhances the clearance of very low-density lipoprotein cholesterol to effectively reduce blood triglyceride levels. This category provides essential reference standards for the Serfibrate active pharmaceutical ingredient, alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for precise analytical testing, robust method validation, and accurate impurity profiling. The inclusion of stable isotope labelled internal standards facilitates reliable quantification in complex biological matrices, ensuring compliance with rigorous quality control protocols throughout the drug development lifecycle.